• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911416220
Device Problem Occlusion Within Device (1423)
Patient Problems Chest Pain (1776); Dyspnea (1816); Myocardial Infarction (1969); Nausea (1970); Reocclusion (1985); ST Segment Elevation (2059); Ventricular Fibrillation (2130); Diaphoresis (2452)
Event Date 07/30/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr : the device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Event Description
Same case as mdr id 2134265-2017-10703.(b)(6) clinical study.It was reported that myocardial infarction (mi) and in-stent restenosis (isr) occurred.In (b)(6) 2012, the patient presented due to unstable angina and was referred for cardiac catheterization.Subsequently, index procedure was performed.The target lesion was a de novo lesion located in the first diagonal branch with 100% stenosis and was 12 mm long with a reference vessel diameter of 2.25 mm.The target lesion was treated with pre-dilatation and placement of a 2.25 mm x 16 mm promus element¿ plus drug eluting stent.Following post dilatation, residual stenosis was 0%.On the following day, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2017, the patient presented to the emergency room with the complaints of chest pain located in the sub sternal area radiating to the jaw, shortness of breath, diaphoresis and nausea.The patient took 325 mg of salicylate prior to calling the emergency medical services (ems).Upon arrival in the emergency room, the patient's electrocardiogram (ecg) was unremarkable and the troponin levels were normal.The patient continued to have chest pain and developed ventricular fibrillation in the emergency department.The patient was defibrillated and started on an antiarrhythmic.The patient was emergently taken to cardiac catheterization lab which revealed 100% stenosis located in proximal left anterior descending (lad) and 40% isr at the ostium of the first diagonal branch.On the same day, the 100% stenosis in the proximal lad was treated with pre-dilatation and placement of a 3.0 x 12 mm synergy stent.Following post-dilatation, the residual stenosis was 10%; however, after the procedure, a timi flow reduction was noted, from timi 3 to timi 2.A balloon angioplasty was performed successfully in response to the timi flow reduction.Four days later, the patient was discharged on clopidogrel and aspirin.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that following the index procedure, timi 3 flow was noted.In (b)(6) 2017, the patient's electrocardiogram revealed normal sinus rhythm, septal infarct, age undetermined and st elevation, consider early repolarization, pericarditis, or injury.St segment elevation myocardial infarction (mi) occurred.No stent thrombosis was noted.Cardiac enzyme elevation noted post procedure was due to original progression of mi.Four days later, the event was considered as resolved and the patient was in stable condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6987113
MDR Text Key90550287
Report Number2134265-2017-10688
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/01/2013
Device Model NumberH7493911416220
Device Catalogue Number39114-1622
Device Lot Number15154228
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/11/2017
Initial Date FDA Received10/30/2017
Supplement Dates Manufacturer Received02/05/2018
Supplement Dates FDA Received02/28/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/24/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age52 YR
-
-